source
- ARPA-H grants funding to biotech firms developing custom RNA therapies amid broader biotech updatesARPA-H is providing grants to several biotech companies to develop custom RNA therapeutics, aiming to accelerate personalized medicine. Roche has licensed a tri‑specific antibody, adding a new mod…
- Biotech reverse mergers surge 1,600% in Q3, matching number of IPOs in 2026Biotech companies are turning to reverse mergers as a faster, less volatile route to the public markets. In the third quarter of 2026, 17 reverse mergers were completed or announced, a 1,600% incre…